Washington Committee Holds Public Hearing on Psilocybin Bill

Today, Washington’s House Health Care & Wellness Committee held a public hearing on House Bill 1433, a measure to legalize medical psilocybin in a highly regulated manner.

Dried psilocybin mushrooms (photo credit: Shutterstock).

Filed by State Representative Nicole Macri (D) with 29 sponsors, HB 1433 would allow those with a physician recommendation to use psilocybin. The bill would create a structured framework allowing licensed facilitators to administer psilocybin in supervised settings. The Washington State Department of Health and Liquor and Cannabis Board would oversee the program, with input from a newly formed Psychedelic Substances Board responsible for developing licensing requirements and safety protocols.

Senate Bill 5201, a companion bill to HB 1433, is scheduled for a public hearing at 8am February 6 in the Senate Health & Long-Term Care Committee.

The legislation sets a two-year development timeline starting September 1, 2025, with licensing expected to begin by late 2027. Psilocybin production, testing, and distribution would be tightly regulated, restricted to licensed facilities and professionals. Therapy sessions would require a trained facilitator, with an emphasis on cultural competence to ensure accessibility and safety.

The proposal does not allow recreational use, limiting psilocybin strictly to therapeutic purposes.

During today’s public hearing, numerous people spoke in favor of the measure, including two military veterans and a survivor of sex trafficking who argued that psilocybin has helped them with their PTSD, a spokesperson for the Washington Association of Criminal Defense Attorneys who said it would help end the pain associated with criminalizing psilocybin, and several others.

Although many spoke in support, four members of the pro-psychedelic decrim group REACH WA spoke in opposition to the bill, saying that it will lead to expensive sessions while doing nothing to actually remove criminal penalties for accessing, possessing or sharing psilocybin.

In direct contrast to these remarks —though on the same side as they also oppose the bill—two different speakers argued that the measure is a “recreational” bill disguised as a medical bill, and thus lawmakers should oppose it.

Also opposed to the bill was the Psychedelic Medicine Alliance of Washington, saying the bill “does not adequality address access issues such a affordability”. This was a sentiment shared by several other speakers, including registered nurse Angela Ward, who argued that the committee should amend the bill to allow all adults to legally possess and obtain psilocybin.

Speaking in support of the bill was the Washington Retail Association, with a spokesperson arguing that it could help improve public safety and reduce retail theft due to its potential to help address mental health issues.

The hearing concluded with multiple speakers saying they support the concept of the bill, but say the committee should first amend it to include language that decriminalizes the personal possession and use of psilocybin.

Thank you for reading The Marijuana Herald! You can find more news stories by clicking here, and you can sign up for daily news updates by clicking here

 

 

 

More articles from The Marijuana Herald can be found below.

Study: Long-Acting Injectable CBD Shows Weeks-Long Presence in Calves, Suggesting Possible Use for Painful Farm Procedures

Study: Long-Acting Injectable CBD Shows Weeks-Long Presence in Calves, Suggesting Possible Use for Painful Farm Procedures

Bacteria From Hemp Seed Oil Shown to Combat Botrytis, Offering a New Biocontrol Tool for Cannabis Growers

Bacteria From Hemp Seed Oil Shown to Combat Botrytis, Offering a New Biocontrol Tool for Cannabis Growers

Florida Senate Bill Would Allow Qualified Patients to Grow Cannabis at Home

Florida Senate Bill Would Allow Qualified Patients to Grow Cannabis at Home

Oregon Appeal Could Set National Precedent for Adding Female Orgasmic Disorder to Medical Marijuana Programs

Oregon Appeal Could Set National Precedent for Adding Female Orgasmic Disorder to Medical Marijuana Programs

Utah Medical Cannabis Program Has Over 106,000 Active Patients, With Over $160 Million in Sales So Far in 2025

Utah Medical Cannabis Program Has Over 106,000 Active Patients, With Over $160 Million in Sales So Far in 2025

California: Coastal Sun Greenhouse Flower Products Recalled After Presence of Aspergillus niger

California: Coastal Sun Greenhouse Flower Products Recalled After Presence of Aspergillus niger

Senator Blocks Sara Carter’s Nomination for White House Drug Czar After Procedural Dispute

Senator Blocks Sara Carter’s Nomination for White House Drug Czar After Procedural Dispute

Kentucky’s First Medical Marijuana Sales Expected “Within the Next Couple of Weeks”, Says Governor

Kentucky’s First Medical Marijuana Sales Expected “Within the Next Couple of Weeks”, Says Governor

Every Cannabis Bill Filed in U.S. Congress During the 2025-2026 Session

Every Cannabis Bill Filed in U.S. Congress During the 2025-2026 Session

Massachusetts Regulators Sets December 11 Final Vote on Cannabis Consumption Sites

Massachusetts Regulators Sets December 11 Final Vote on Cannabis Consumption Sites

Numerous Signature Gathering Events Scheduled for Idaho’s Medical Cannabis Legalization Initiative

Numerous Signature Gathering Events Scheduled for Idaho’s Medical Cannabis Legalization Initiative

Study Finds Medical Cannabis Linked to Improvements in Fibromyalgia Symptoms, Including Improved Sleep, Anxiety, and Overall Wellness

Study Finds Medical Cannabis Linked to Improvements in Fibromyalgia Symptoms, Including Improved Sleep, Anxiety, and Overall Wellness

U.S. Congress: RESPECT Resolution Introduced to Advance Equity in the Marijuana Industry

U.S. Congress: RESPECT Resolution Introduced to Advance Equity in the Marijuana Industry

The Best Selling Cannabis Strains in Every Recreational State (as of December 2025)

The Best Selling Cannabis Strains in Every Recreational State (as of December 2025)

CBD May Help Stabilize Brain Chemistry in People at High Risk for Psychosis, Study Finds

CBD May Help Stabilize Brain Chemistry in People at High Risk for Psychosis, Study Finds

Massachusetts Marijuana Sales Reach $147 Million in November, $1.66 Billion in 2025, as Prices Fall to New Record Low

Massachusetts Marijuana Sales Reach $147 Million in November, $1.66 Billion in 2025, as Prices Fall to New Record Low

Chicago Council Committee Approves Ordinance to Restrict Hemp-Derived Cannabinoid Sales

Chicago Council Committee Approves Ordinance to Restrict Hemp-Derived Cannabinoid Sales

Florida’s Medical Marijuana Market Tops $1.5 Billion in Sales Through November, With Flower Leading Nearly Half of All Sales

Florida’s Medical Marijuana Market Tops $1.5 Billion in Sales Through November, With Flower Leading Nearly Half of All Sales